Valuation: Star Scientific, Inc.

Market Cap 153K 137K 126K 115K 214K 14.57M 218K 1.51M 605K 7.66M 576K 563K 24.16M P/E 2014
-0.87x
P/E 2015 -1.04x
Enterprise Value 20.01M 17.92M 16.48M 14.94M 27.92M 1.9B 28.44M 197M 78.92M 999M 75.1M 73.5M 3.15B EV / Sales 2014
-
EV / Sales 2015 -
Free-Float
100%
Yield 2014 *
-
Yield 2015 -
Change 5-day change 1-year change 3-year change Capi.($)
+3.19%+11.31%+67.86%+150.58% 1,224B
-0.73%+3.56%+44.51%+85.81% 662B
+1.41%+3.24%+29.22%+107.83% 514B
+0.42%+3.20%+54.15%+67.18% 388B
+2.18%+2.93%+73.30%+45.62% 361B
+1.12%+4.52%+35.30%+58.08% 302B
+6.96%+8.86%+11.27%+36.62% 271B
+1.15%+6.09%+59.59%+77.06% 249B
+3.06%+9.38%+44.11%+119.47% 205B
Average +1.73%+5.61%+46.59%+83.14% 464.09B
Weighted average by Cap. +1.17%+6.35%+50.91%+98.22%

Financials

2014 2015
Net sales - -
Net income -38.52M -34.5M -31.73M -28.75M -53.74M -3.66B -54.75M -378M -152M -1.92B -145M -141M -6.07B -6.84M -6.13M -5.64M -5.11M -9.55M -650M -9.73M -67.25M -26.99M -342M -25.69M -25.14M -1.08B
Net Debt -45K -40.3K -37.07K -33.59K -62.79K -4.27M -63.96K -442K -177K -2.25M -169K -165K -7.09M 19.86M 17.78M 16.36M 14.82M 27.71M 1.89B 28.22M 195M 78.31M 992M 74.52M 72.94M 3.13B
Logo Star Scientific, Inc.
Rock Creek Pharmaceuticals Inc is a United States-based pharmaceutical development company. The Company is focused on the discovery, development and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its activities are focused on its lead compound, anatabine citrate (anatabine). Anatabine is a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics. The Company focuses on dermatological skin diseases, such as psoriasis, eczema and rare or orphan skin disorders, using its formulations of anatabine.
Employees
-